Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQ4N in Lymphoid Neoplasms
NCT00109356Phase 2Unknown
- Sponsor
- Novacea
- Start
- Mar 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of banoxantrone in non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), chronic lymphocytic leukemia (SLL/CLL), sponsored by Novacea. Status: unknown.
02
Drugs
banoxantrone
03
Conditions
non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)chronic lymphocytic leukemia (SLL/CLL)
Beyond the preview
Go deeper on NCT00109356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109356.